MUP is one of the most recent pharmaceutical firms in Egypt. In the scenic region near the city of Ismailia, MUPhas established a modern pharmaceutical manufacturing facility which incorporates many contemporary construction design features, raw materials handling, production concepts, and state-of-the-art manufacturing lines which rival the most modern American, European and Japanese counterparts. MUP adopts the Total Quality Management (TOM) concept and methodology in all departments and up-to-date Quality Assurance (QA) techniques, not only in all production processes, but also in all administrative and supporting departments.
MUP acquired the latest ISO 9001:2008 Certificate from the British Standards Institute (bsi), and recently upgraded the conventional plant to be certified to ISO, 14001, 18001 & 17025 by the end of year 2015 . MUP is proceeding in the new Cephalosporin and Penicillin Plants and all sets for the EMEA certification.
Today, MUP provides trusted generic, branded generic and specialty pharmaceutical products to more than 30 countries in Africa, the MENA region, and Western Europe and are aggressively building a leading position in providing international initiatives satisfying countries and communities that collaborate with us. MUP provides many products that cover several therapeutic areas, such as:
Gastroenterology, Dermatology, Gynecology, Andrology, Cardiovascular, Dentistry, Anti-Infectives, Vitamins and Tonics, Anti-Histaminics, Analgesics and Anti-Rheumatics, Endocrinology, Hepatology, Respiratory, Neurology.
Contact
Headquarters
MUP, Inc. 36 Dr . Mohammad Hassan El-Gamal St., 6th District-Nasr City- Cairo-A.R.E P.O.Box : 7010 Nasr City Kost No : 11768 Tel : (+20) 22709324 / 22709316 / 22709535 / 22726169 Fax : (+20) 22709315
Medical Union Pharmaceuticals (MUP) acquired Lilly’s Egyptian human insulin vial manufacturing facility in early 2015. Managing Director Ahmed Kelani discusses the national significance of this acquisition given Egypt’s high prevalence…
Concerted efforts are, at last, being made to redraw the rulebook and tidy up a local regulatory landscape long renowned for its torpor, dysfunction and ineffectuality. The Egyptian pharmaceutical market…
In an exclusive discussion with Focus Reports, Egyptian Minister of Health, Dr. Ahmed El Din Rady sets out his blueprint for improving the nation’s welfare and securing positive public health…
Ten years after his first interview with Focus Reports, Wafik Bardissi discusses Minapharm’s position as the leading biosimilar manufacturer in the Middle East. Has Egypt taken steps to incentivize the development or registration…
Fresenius Kabi’s general manager for the MENA region discusses evolving attitudes towards clinical nutrition for critically ill patients and Egypt’s positioning as a knowledge center and source of medical professionals…
Former Egyptian Minister of Health Adel Adawy discusses the reforms needed in the Egyptian healthcare system and the progress made in the fight against HCV over the last two years.…
Japanese company Otsuka envisioned Egypt as a hub for its Middle East and African operations as early as 1995. The president of the local subsidiary discusses the current activities of…
Oncology already represents the second largest portion of Egypt’s public healthcare budget, and despite limited public funding, demand for and acceptance of innovation is high, according to Roche’s regional general…
While growth forecasts for the MENA region remain high, falling oil prices and political instability are creating significant government budgetary challenges for the industry to adapt to. Janssen’s area managing…
“My primary concern is not the current economic situation, but rather the fact that there does not appear to be a clear vision for how Egypt can overcome these challenges…
The founder of the Middle East’s largest pharmaceutical company, EIPICO, discusses the evolution of the Egyptian pharmaceutical industry over the last 50 years, and his hopes for the industry over…
Eva Pharma is one of the fastest growing pharmaceutical companies in the MENA region, and CEO Riad Armanious is aiming to take the company from the 21st ranked generic company…
After choosing Egypt as the first country to host a production plant in the Middle East, AstraZeneca is interested in strengthening its foothold in the market. The country president discusses…